Role of high-dose chemotherapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
High-dose chemotherapy (HD-CT) in combination with autologous stem cell transplantation (auto-SCT) has long become the gold standard treatment for chemosensitive recurrences and refractory diffuse large B-cell lymphoma (DLBCL).By taking into account the low efficiency of rescue therapy (postrecurrence five-year survival rate is not more than 10-20%